ABT - Abbott Laboratories
92.10 0.00 (0.00%)
After hours: 7:48PM EDT
Chart Events
Performance Outlook
- Short Term2W - 6W
- Mid Term6W - 9M
- Long Term9M+
| Previous Close | 90.76 |
| Open | 91.95 |
| Bid | 91.94 x 1000 |
| Ask | 92.44 x 800 |
| Day's Range | 91.21 - 93.32 |
| 52 Week Range | 61.61 - 100.00 |
| Volume | 5,181,810 |
| Avg. Volume | 11,151,467 |
| Market Cap | 162.911B |
| Beta (5Y Monthly) | 0.97 |
| PE Ratio (TTM) | 46.26 |
| EPS (TTM) | 1.99 |
| Earnings Date | Jul 15, 2020 - Jul 20, 2020 |
| Forward Dividend & Yield | 1.44 (1.59%) |
| Ex-Dividend Date | Apr 14, 2020 |
| 1y Target Est | 102.13 |
- Zacks
Abbott (ABT) Gains But Lags Market: What You Should Know
Abbott (ABT) closed at $90.76 in the latest trading session, marking a +1.43% move from the prior day.
- Financial Times
UK regulator halts antibody home tests for coronavirus
UK regulators have asked all coronavirus antibody test providers that use a blood sample taken with a finger prick to halt operations as doubts persist over their accuracy. On Wednesday, the Medicines and Healthcare products Regulatory Agency’s director of devices, Graeme Tunbridge, said the use of unvalidated samples may lead to unreliable results. “People who have purchased one of these sampling kits, and received an antibody test result, should not consider the result to be reliable and should not take any action on it,” he said.
- Motley Fool
Coronavirus 2020: Where to Invest $500 Right Now
These three stocks are leaders in the fight against COVID-19 and have compelling growth prospects beyond their coronavirus programs.
- Insider Monkey
Abbott Laboratories (ABT): Hedge Funds Are In Wait-and-See Mode
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F […]
- Investor's Business Daily
Is Abbott Stock A Buy As Coronavirus Test Accuracy Called Into Question?
Medical company Abbott has now launched five coronavirus tests. It's expected to take a sizable share of the market. But researchers are questioning test accuracy. Is ABT stock a buy now?
- Motley Fool
3 Large-Cap Coronavirus Stocks Still Worth Buying
Abbott Labs (NYSE: ABT) made headlines in late March when the FDA gave emergency use authorization (EUA) for the company's COVID-19 test that runs on its ID NOW platform. Abbott also announced interim results last week from a clinical study in urgent care clinics that showed high levels of sensitivity for positive results and specificity for negative results.
- Motley Fool
Is Abbott Labs Stock in Trouble?
With more than 5 million cases of COVID-19 now around the globe, one area where there's been significant demand has been in coronavirus testing. In March, Abbott Laboratories (NYSE: ABT) launched a coronavirus test that the company said could deliver results in just five minutes. A study out of New York University (NYU) is raising serious concerns around just how accurate Abbott's ID NOW test is in detecting COVID-19.
- GuruFocus.com
US Indexes Post Some Small Gains Friday Before the Holiday Weekend
Nasdaq has a gain of 3.92% for the year Continue reading...
- Bloomberg
U.S. Cases Up 1.8%; Trump Pushes to Open Churches: Virus Update
(Bloomberg) -- President Donald Trump declared houses of worship as essential and directed governors to let them open “right now,” even though legal experts said he lacks the authority to override stay-at-home orders.Anthony Fauci, the nation’s top infectious disease expert, said it may be time to consider a cautious reopening of the economy. New York Governor Andrew Cuomo said two more regions, including Long Island and Westchester County, could open next week if they meet certain metrics.Oxford University and AstraZeneca started recruiting for advanced human studies of one of the fastest-moving experimental vaccines, while a Russian institute said it used laboratory staff in a successful unofficial test on a potential vaccine.Key Developments:Virus Tracker: Cases top 5.1 million; deaths around 336,000Coronavirus is a stress test many world leaders are failingMillions face risk of virus contagion in storm-hit South AsiaDefault notices pile up as shuttered retailers can’t pay rentNobody’s happy about all the contact-tracing apps out nowBankers to the ultra-rich deprived of glamor turn to ZoomScared and sick, U.S. meat workers crowd into reopened plantsSubscribe to a daily update on the virus from Bloomberg’s Prognosis team here. Click VRUS on the terminal for news and data on the coronavirus. For a look back at this week’s top stories from QuickTake, click here.U.K. Police Question Johnson Aide (5:37 p.m. NY)Boris Johnson’s chief adviser was interviewed by police for potentially breaking the U.K. government’s lockdown rules when he self-isolated with coronavirus symptoms. Police spoke to Dominic Cummings after he was seen more than 250 miles (400 kilometers) from his London home shortly after he went into isolation at the end of March -- a time when the prime minister and Health Secretary Matt Hancock had both tested positive.At the time, U.K. citizens were under orders not to travel, and to stay at home. Cummings, a divisive behind-the-scenes figure within the administration, lives in London while his parents live in Durham, in northern England.Peru Continues Reopening Economy (5:15 p.m. NY)Peru authorized more businesses to reopen, including hairdressers, electricians and online clothes retailers along with mining, fishing and construction companies that were cleared to reopen this month. The lockdown, which was set to expire Sunday, will continue through June 30, President Martin Vizcarra said.Peru is battling South America’s biggest coronavirus outbreak after Brazil, with total cases surpassing 100,000 this week. Strict lockdown measures in place since mid-March have taken a heavy toll on the economy, with economic activity slumping 16% in March and more than a million jobs lost in Lima in the three months to April.California to Issue Religious Guidance (4:45 p.m. NY)California Governor Gavin Newsom said he’ll issue guidelines for reopening places of worship no later than Monday. In-person religious gatherings have so far been prohibited as the nation’s most populous state slowly lifts restrictions on residents.“We take the issue very, very seriously and to heart, and we’ve been very aggressive in trying to put together guidelines that will do justice to people’s health and their fundamental need and desire to practice their faith,” Newsom said at his daily briefing. President Donald Trump said earlier Friday that he would override governors who fail to reopen places of worship this weekend, without explaining what authority he had to do so.Newsom also said he was days away from issuing plans on reopening salons, barbershops and casinos.N.Y. Calls off Car Show (4:30 p.m. NY)Organizers of the New York auto show who had postponed the event to August are now calling it off for this year. “Because of the uncertainty caused by the virus, we feel it would not be prudent to continue with the 2020 show,” Mark Schienberg, president of the Greater New York Automobile Dealers Association, said in a statement.The annual event’s traditional venue, the Javits Convention Center in New York City, is being used as a field hospital. That has forced organizers of the auto show to abandon a summer show and instead push it to next April.CDC Cites Choirs, Collection Plate in Guidance (4:15 p.m. NY)Religious groups should consider suspending or limiting choirs or singing during services and avoid passing a collection plate, the U.S. Centers for Disease Control and Prevention said in guidance issued hours after Trump demanded governors immediately open houses of worship. “The act of singing may contribute to transmission of Covid-19, possibly through emission of aerosols,” the CDC warned.Churches should stay in contact with local and state officials as reopening decisions are made, and provide protection for staff or congregants who are at higher risk of infection. The guidance encouraged hand washing, use of face coverings and increased cleaning and disinfection measures.“The information offered is non-binding public health guidance for consideration only; it is not meant to regulate or prescribe standards for interactions of faith communities in houses of worship,” the CDC said.U.S. Cases Increase 1.8% (4 p.m. NY)Coronavirus cases in the U.S. increased 1.8% as compared to the same time yesterday to 1.59 million, according to data collected by Johns Hopkins University and Bloomberg News. That’s above the 1.5% average of the psat week. Deaths rose 1.7% to 95,490.New York cases rose 0.5% to 358,154, in line with the average increase over the past seven days, according to the state’s health department.Florida cases rose 1.6% to 49,451 on Friday, compared with an average increase of 1.7% in the previous seven days, according to data from the state’s health department. Deaths rose 2.1% to 2,190.Cases in California rose 2.6% to 88,444 while deaths increased 2.5% to 3,630, according to the state’s website.Cases Reach All African Nations: WHO (3:15 p.m. NY)Every nation in Africa now has coronavirus cases, as the continent’s infection total exceeds 100,000, the World Health Organization said. The first Africa case was reported 14 weeks ago.Africa’s mortality rate has been low, with 3,100 confirmed deaths. By comparison, when cases reached 100,000 in Europe, deaths topped 4,900, WHO said. Early analysis suggests the lower mortality rate may reflect that Africa is the youngest continent, with more than 60% of the population under age 25. In Europe nearly 95% of deaths occurred in those older than 60.Cases continue to rise and while overall it took 52 days to reach the first 10,000 cases, it took only 11 days for Africa to move from 30,000 to 50,000 cases, WHO said.California Cases Rise 2.6% (2:53 p.m. NY)California’s confirmed cases climbed 2.6%, above the seven-day average of 2.37%, to a total of 88,444. There were 88 additional deaths, a 2.5% increase, for a total of 3,630.Trump Orders Churches Reopened (2:18 p.m. NY)President Donald Trump declared churches, synagogues and mosques to be essential services and ordered them opened immediately. State governors, whose stay-at-home orders precluded large gatherings for religious services, must let churches open this weekend, he said, though legal experts said he doesn’t have the authority to override state laws.“The governors need to do the right thing and allow these very important essential places of faith to open right now,” Trump said in a White House statement.Religious organizations have been notable sites of outbreaks. In mid-March, a Bible study group meeting was tied to an outbreak of 35 confirmed cases in a rural county in Arkansas, according to a CDC report Tuesday.Ireland Mulls Traveler Isolation (1:30 p.m. NY)Ireland reported 115 new cases, the most in a week, ending a six-day stretch of fewer than 100 daily infections. There were 11 new deaths. Ireland said it will force travelers arriving in the country to detail their whereabouts for the first 14 days of their stay and is considering whether to force travelers to self-isolate for two weeks. The country has 1,592 deaths and 24,506 cases.Fauci: Time to Look at Cautious Reopening (1 p.m. NY)Anthony Fauci, head of the National Institute of Allergy and Infections Diseases, said it may be time to begin to “seriously”’ look at reopening the economy in a cautious way.“I don’t want people to think that any of us feel that staying locked down for a prolonged period of time is the way to go,” Fauci said in a CNBC interview. Staying closed for too long may cause “irreparable damage,” said Fauci, a member of the White House coronavirus task force.N.Y. Adds 2 Regions to Reopen (12:40 p.m. NY)Long Island and the Mid-Hudson region -- including Westchester County -- are on track to reopen, provided deaths continue to fall and contact-tracing targets are met, Governor Andrew Cuomo said. The state had 109 deaths on May 21, for a total of 23,192.With those areas, nine of 10 New York regions will have begun phased-in restarts, after more than seven weeks on lockdown. New York City still has met only four of seven metrics, due largely to a lack of capacity at city hospitals. It also must continue to build up its number of tracers, according to state data.Mayor Bill de Blasio said the city is moving toward a first phase of reopening, focusing on construction, wholesale distribution and curbside retail, by the middle of June.U.K. to Fine Quarantine Violators (12:30 p.m. NY)Passengers arriving in the U.K. will be forced into quarantine for two weeks and face fines of 1,000 pounds ($1,200) if they break the rules, Home Secretary Priti Patel said.The plan, starting June 8, is designed to stop travelers introducing the virus after becoming infected overseas, and is likely to have a major impact on the aviation industry’s attempts to recover from the lockdown. The measures will be reviewed every three weeks, along with the rest of the government’s response.“Now we are past the peak of this virus, we must take steps to guard against imported cases,” Patel said.Italy’s Deaths, New Cases Remain Low (12:10 p.m. NY)Italy’s new cases remained below 1,000 for a 10th day on Friday, as health authorities said the epidemic’s curve is consistently descending in all regions, including Lombardy, the hardest-hit area. Authorities reported 652 cases, up from 642 a day earlier, for a total of 228,658. Daily fatalities were 130, down from 156 on Thursday, bringing the death toll to 32,616.Miami-Dade Sets Beach Opening (11:57 a.m. NY)Miami-Dade, Florida’s most populous county and home to Miami Beach, is targeting June 1 to reopen its famed seashore, the next major step for the region to emerge from its shutdown.Mayor Carlos Gimenez’s office said he agreed on the date in a virtual meeting Friday with mayors and city managers from communities on the coast. Officials will meet this weekend to craft rules for reopening, and meet with Gimenez on Tuesday.Miami-Dade began a phased reopening this week, but tourism has remained essentially shuttered.N.J. Eases Outdoor Crowd Limits (11:55 a.m. NY)New Jersey will permit outdoor gatherings of 25 people, up from 10, Governor Phil Murphy said. Indoor gatherings will still be limited to 10 people, he said at a news conference in Trenton. The state reported 146 new deaths, bringing the toll 10,985. An additional 1,394 new cases were reporting, pushing the total to 152,719, Murphy said.China Vaccine Shows Promise: Lancet (11:20 a.m. NY)An experimental vaccine developed by CanSino Biologics of China was safe and generated an immune response in an early study in humans.The vaccine stimulated production of both antibodies that can stop infection along with immune T-cells, according to a report Friday in The Lancet medical journal. Further research is needed to show its effectiveness against the virus, according to the study funded by CanSino and conducted by researchers from the Beijing Institute of Biotechnology and other organizations.“The challenges in the development of a Covid-19 vaccine are unprecedented, and the ability to trigger these immune responses does not necessarily indicate that the vaccine will protect humans from Covid-19,” said Wei Chen, a professor at the Beijing institute that carried out the study, in the report.Infants Seen at Risk From Vaccine Disruption (11:14 a.m. NY)As the coronavirus pandemic disrupts routine visits to doctors’ offices, more than 80 million children under the age 1 are at risk of life-threatening diseases like polio and measles, according to the world’s top health agencies.Routine vaccinations of children have been substantially hindered in at least 68 countries, according to data from the World Health Organization; UNICEF; the Sabin Vaccine Institute; and Gavi, the Vaccine Alliance, which helps immunize half the world’s children against diseases.The agencies said Friday that immunization services “have been disrupted on a global scale that may be unprecedented since the inception of expanded programs on immunization (EPI) in the 1970s.” They called upon countries to join an effort to resume campaigns against vaccine-preventable diseases and made recommendations on how to safely deliver shots amid the pandemic.Florida Cases Rise 1.6% (11:10 a.m. NY)Florida reported 49,451 Covid-19 cases on Friday, up 1.6% from a day earlier, compared with an average increase of 1.7% in the previous seven days. Deaths among Florida residents reached 2,190, an increase of 2.1%.The report marked a return toward the recent mean, after Thursday’s release showed the sharpest percentage uptick in case numbers since May 1. Florida is coming to the end of a week in which Miami-Dade and Broward, its most populous counties, joined the rest of the state in a phased reopening.Speaking Friday in Jacksonville, Governor Ron DeSantis said he’s lifting restrictions on youth activities including sports and summer camps.Cyprus Reopens Foreign Flights (10:40 a.m. NY)Cyprus will start allowing direct flights from some European countries on June 9, and it plans to end a mandatory 14-day quarantine for arriving visitors on Monday and reopen hotels on June 1.In the first stage, Cyprus will permit flights from Greece, Malta, Bulgaria, Norway, Austria, Finland, Slovenia, Hungary, Israel, Denmark, Germany, Slovakia and Lithuania. A second phase on June 20 will add Switzerland, Poland, Romania, Croatia, Estonia and the Czech Republic.Malaria Drugs Linked to Death, Heart Risk (9:30 a.m. NY)The antimalaria drugs touted by U.S. President Donald Trump to treat Covid-19 patients were linked to an increased risk of death and heart ailments in a study published in The Lancet medical journal. Trump said Monday that he had taken the drug for about a week.Hydroxychloroquine and chloroquine didn’t benefit the patients either alone or in combination with an antibiotic, according to the study based on records of 15,000 people treated with the antimalarials and one of two antibiotics often paired with the drug. Treatment with any combination of the four drugs was associated with a higher risk of death than seen in 81,000 patients who didn’t receive them, the study found.Puerto Rico Cases Surpass 3,000 (8:14 a.m. NY)Confirmed coronavirus cases in Puerto Rico surpassed the 3,000 mark on Friday, as the Health Department said an additional 117 people had tested positive. This is the third time this month that more than 100 cases were detected in a 24-hour period.According to government figures, the pandemic has now affected 3,030 people and 126 have died. The figures come as the commonwealth of 3.2 million people pushes ahead with plans to reopen the economy after declaring a broad lock-down on March 16. On Tuesday, malls, retail outlets and restaurants will be allowed to resume operations.Russia Tests Covid-19 Vaccine on Researchers (8:10 a.m. NY)A Russian government research institute said it conducted successful unofficial tests on a potential coronavirus vaccine. Laboratory staff who volunteered to receive the vaccine at the Gamaleya epidemiology institute in Moscow had no side effects and are healthy, said its director, Alexander Ginzburg, the state-run Tass news service reported.It didn’t state how many people took part in the trial.Fauci Optimistic About Moderna Vaccine (7:36 a.m. NY)Moderna shares rose after Anthony Fauci, the leading U.S. infectious disease official, said he was optimistic about the company’s vaccine. “Even though there were only eight individuals, we saw neutralizing antibodies at a reasonable dose of the vaccine,” Fauci said on CNN. “Although the numbers were limited, it was really quite good news because it reached and went over an important hurdle in the development of vaccines. That’s the reason why I’m cautiously optimistic about it.”Fauci said on NPR that he expects the full results of a Phase 1 study of the biotech’s experimental Covid-19 vaccine within weeks. Earlier this week, an experimental vaccine from the company showed signs that it can create an immune-system response to fend off the new coronavirus. In 25 people who got either of the two smaller doses used in the study, researchers reported that the levels of antibodies equaled or exceeded the levels of antibodies found in patients who had recovered from the virus.The second test, evaluating the quality of those antibodies, was only available for eight of the people because it takes longer to perform. But in all eight people, the vaccine successfully stimulated the body to create antibodies capable of neutralizing the virus in the test tube, so it can no longer infect cells.Alibaba Growth Slows; Deere Tractor Sales Hold Up (7:15 a.m. NY)Alibaba Group Holding Ltd. reported its slowest pace of revenue growth on record after China’s economic contraction drove down spending across its online marketplaces. The results demonstrate the world’s second largest economy has yet to fully shake off Covid-19, with consumers still hesitant about spending on big-ticket items.Deere & Co. shares rose after the world’s biggest tractor maker navigated coronavirus upheavals better than expected in the height of the pandemic. For the three months through April, sales and earnings fell less than analysts projected as agriculture -- deemed essential in the lockdown era -- proves more resilient than many other industries.U.K. Contact-Tracing App Roll-Out Delayed (6:20 a.m. NY)Britain’s mobile phone app for tracking coronavirus infections has been delayed by bureaucracy and the addition of more symptoms to monitor, according to a person familiar with the matter -- who said they expected the government to abandon it in favor of the model backed by Apple Inc and Alphabet Inc.’s Google.The app is being developed by VMware Inc. and Zuhlke Engineering Ltd at a cost of 4.7 million pounds ($5.8 million). There has been controversy about the U.K.’s decision to reject the structure backed by Apple and Google, a move that has been criticized by privacy campaigners.The U.K. has opted for a “centralized” model, where people who test positive for coronavirus upload all their recent contacts to a database, and those people are then contacted and warned. Apple Inc. and Google released their Covid-19 exposure-notification tools on Wednesday. Some governments have criticized the “decentralized” system because it doesn’t let authorities store data on who has the virus and track where it is spreading. Instead, it just notifies individuals if they have been exposed.Germany Plans One-Time Child Bonus (6 a.m. NY)German Finance Minister Olaf Scholz is planning a one-time bonus for families of 300 euros ($327) per child as part of a government stimulus program worth as much as 150 billion euros, Der Spiegel magazine reported, without identifying the source of its information. The bonus could cost the government 5 billion to 6 billion euros. Scholz is also considering vouchers to boost consumer spending.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.
- MarketWatch
CDC faces more coronavirus testing questions, this time about how many diagnostic tests are being conducted
The Centers for Disease Control and Prevention (CDC) confirmed that it has been combining the number of molecular tests used to diagnose active COVID-19 infections with the number of serologic tests that can detect antibodies in its testing tally.
- Investor's Business Daily
How Quidel's New Test Could Be A Game-Changer In Coronavirus
Diagnostics company Quidel is launching a new type of coronavirus test that looks for antigens. It could be faster, easier to use and cheaper to produce than its any of its predecessors.
- TheStreet.com
Hong Kong, Alibaba and Nvidia - 5 Things You Must Know Friday
Dow futures rebound as China announces plans to impose new national security laws on Hong Kong. Alibaba reports earnings.
- MarketWatch
This new coronavirus test will give on-the-spot results within 20 minutes
Just days after the Food and Drug Administration cautioned about the reliability of an Abbott Laboratories test, the U.K. Government announces Optigene breakthrough.
- Zacks
Abbott (ABT) Gains As Market Dips: What You Should Know
In the latest trading session, Abbott (ABT) closed at $90.39, marking a +0.33% move from the previous day.
- Reuters
Abbott says new data on rapid coronavirus test used in White House shows high accuracy
Abbott Laboratories on Thursday said an analysis of data from an ongoing study of its ID NOW rapid test, which is used in the White House and elsewhere to spot COVID-19, shows it is highly accurate when compared with industry-standard tests. Abbott's data has so far shown that the test, which can be used at the point of care and produces results in minutes, finds positive cases of COVID-19 nearly 95% of the time when compared with two other tests performed in laboratories. The U.S. Food and Drug Administration said last week that Abbott's speedy coronavirus diagnostic test could potentially be inaccurate.
- PR Newswire
Abbott Releases Interim Clinical Study Data on ID NOW COVID-19 Rapid Test Showing Strong Agreement to Lab-Based Molecular PCR Tests
Abbott (NYSE: ABT) announced today an interim analysis of an ongoing multi-site clinical study in urgent care clinics that indicates its ID NOW COVID-19 rapid test is showing strong agreement to lab-based molecular polymerase chain reaction (PCR) instruments. The interim results are demonstrating ID NOW COVID-19 test performance is ≥94.7% in positive agreement (sensitivity) and ≥98.6% negative agreement (specificity) when compared to two different lab-based PCR reference methods.
- Bloomberg
U.K. Buys 10 Million Antibody Tests from Roche and Abbott
(Bloomberg) -- The U.K. agreed to buy 10 million coronavirus antibody tests from Swiss pharmaceutical giant Roche Holding AG and Abbott Laboratories Ltd, in a boost to Prime Minister Boris Johnson as he tries to ease the country back to normality.The tests will be crucial to aid understanding of the spread of the disease, Health Secretary Matt Hancock said Thursday at a press conference from 10 Downing Street. They will be rolled out in a phased way starting next week, he said.“This is an important milestone and it represents further progress in our national testing program” Hancock said. “Knowing that you have these antibodies will help us to understand more in the future: if you are at lower risk of catching coronavirus, of dying from coronavirus and transmitting coronavirus.”Making antibody tests widely available may help Britain lift its lockdown restrictions, because they show who has already had the virus and might have a degree of immunity. That would mean they could resume social contact with others. However, scientists still aren’t sure whether having antibodies means long-lasting protection from the disease.In other developments on Thursday:A trial began of a 20-minute test to show whether patients have coronavirusA surveillance study carried out for the government suggested 17% of Londoners and 5% of the national population has had the virus, based on the presence of Covid-19 antibodiesUnder political pressure, Johnson ditched a plan to make migrant workers in the NHS and care homes pay a health surcharge, promising them an exemptionRoche’s test, which was cleared by a U.K. health authority earlier this month, had previously garnered praise in Germany and the U.S. for its reliability. It won emergency use in the U.S. earlier this month and clearance for countries accepting Europe’s CE marking. Roche expects production to reach the high double-digit millions by June and pass the 100 million monthly threshold later this year.Abbott on May 15 said its test had been approved for use in the U.K. and that it could supply as many as 5 million a month. The test has also been approved in Canada.The antibody tests will be free to access through the National Health Service and care workers would be prioritized, Hancock said. Johnson previously described antibody tests as a “game-changer” in the response to the virus.Hancock said a separate coronavirus test developed by the manufacturer OptiGene has been put into trials from Thursday. It can show whether a patient has the virus within 20 minutes. “We will monitor its effectiveness very closely, and if it works, we’ll roll it out as soon as we can,” he said. A successful, fast test would help track the spread of the virus.U-TurnThe OptiGene test has been “highly effective” when used in clinical settings, and will now be tried out in care homes, doctors’ offices and emergency units, the Health Department said. As many as 4,000 people will be tested in the county of Hampshire in southern England.Despite the positive news on testing, Johnson also suffered a political blow Thursday when his government was forced into a U-turn over a health care surcharge to migrant NHS and care home workers that the premier had defended in the House of Commons on Wednesday.At the weekly session of Prime Minister’s Questions on Wednesday, opposition Labour Party Leader Keir Starmer had asked Johnson if he thought the 400-pound charge -- set to rise to 624 pounds -- was “right.” The premier responded that while he appreciated the “importance” of the question, the charge was “the right way forward,” bringing 900 million pounds into the NHS a year.But on Thursday he changed tack, with his office saying the premier has asked ministers to remove NHS and care workers from the surcharge “as soon as possible.”(Adds details of Johnson U-turn in final three paragraphs.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.
- PR Newswire
Abbott Announces Contract to Supply Millions of IgG Lab-Based Antibody Tests to the UK Government
Abbott (NYSE: ABT) announced a government contract to supply millions of its laboratory-based IgG antibody tests to National Health Service (NHS) laboratories across the UK over the coming months. Abbott has capacity to provide significant numbers of tests to the UK and has already shipped 800,000 antibody tests this week to NHS laboratories, to be used as part of the testing initiative announced by the UK Secretary of State for Health today. These tests, alongside the Abbott PCR tests already being used across the NHS, enable Abbott to support the UK with broad, reliable molecular and antibody testing during this pandemic.
- Reuters
Britain signs deals for 10 million antibody tests from Roche and Abbott
Britain will buy 10 million coronavirus antibody tests from Roche and Abbott and will roll them out to health workers from next week, health minister Matt Hancock said on Thursday. The antibody tests - also known as serology tests - show who has been infected, although it is not yet clear whether the presence of antibodies to the new coronavirus, SARS-CoV-2, confers permanent immunity. "We have signed contracts to supply in the coming months over 10 million tests from Roche and Abbott," Hancock said.
- CNW Group
Abbott Announces Health Canada Authorization Under the COVID-19 Interim Order and Immediate Availability of its COVID-19 Antibody Test in Canada
- New antibody blood test will run on Abbott's ARCHITECT® i1000SR and i2000SR laboratory-based instruments and will expand to its Alinity™ i system. - Abbott expects to begin shipping antibody tests to Canada this week and intends to distribute 30 million tests globally by the end of June. Abbott is already providing its COVID-19 molecular test for its m2000™ instrument in Canada .
- Financial Times
Free NHS antibody tests on way after Roche and Abbott Labs deals
An antibody test to show whether someone in the UK has had coronavirus will be made available through the NHS after the government announced it had agreed deals with Swiss pharma company Roche and American competitor Abbott Laboratories. Matt Hancock, health secretary, said the UK had agreed to buy 10m antibody tests initially, which will be rolled out in a “phased way” from next week. Frontline NHS and care workers will be prioritised for the free tests, which detect past Covid-19 infection.
- Financial Times
Will antibody tests be our passport to normality? | Free to read
In February, I developed the worst chest infection of my life, so persistent that one night, while eating in a restaurant, I had to go home mid-meal because I could not stop coughing. When a test that could apparently prove I had contracted coronavirus first became commercially available in New York last month, I asked my doctor to send me for a blood draw. Rather than testing whether a person has an active infection, these tests perform a sort of biological archaeology, searching for pathogen-fighting proteins known as antibodies that show a person has had the illness in the past and possibly developed enough immunity to fend it off in the future.
- Moody's
Abbott Ireland Financing DAC -- Moody's announces completion of a periodic review of ratings of Abbott Laboratories
Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Abbott Laboratories and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers.
- Motley Fool
Is Abbott Labs Stock a Buy After Its COVID-19 Test Controversy?
The fastest COVID-19 test on the market just encountered some turbulence. But does this create a buying opportunity for long-term investors?
ACCESSWIREIMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Abbott Laboratories and Encourages Investors with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / May 16, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Abbott Laboratories ("Abbott" or "the Company") (NYSE:ABT) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Based on this news, shares of Abbott dropped in intraday trading on May 15, 2020.
